Biotech Stocks to Buy Based on Predictive Statistics: 132% In 30 Days

Biotech Stocks to Buy

The BioTech stocks package includes biotech stocks to buy, is designed for investors and analysts who need predictions of the best deep-value stocks to buy for the whole Biotechnology Industry (See Industry Package). It includes 20 stocks with bullish and bearish signals and indicates the best biotech stocks to invest in:

  • Top 10 biotech stocks for the long position
  • Top 10 biotech stocks for the short position

BioTech StocksPackage Name: BioTech Stocks
Forecast Length: 1 Month (08/28/16– 09/28/16)
I Know First Average: 20.53%

Biotech Stocks to Buy

During the 30 days forecasted period, several top biotech stocks had seen significant returns throughout the period. The biotech stocks with the highest return had come from Sarepta Therapeutics, Inc. (SRPT), at 132.41%, during the 30 days period. Additional notable returns came from Ariad Pharmaceuticals, Inc. (ARIA), Raptor Pharmaceutical Corp. (RPTP), 37.95%, and 23.25%, respectively. The BioTech Stocks package had an overall average return of 20.53%, providing investors with a premium of 20.42% over the S&P 500’s return of 0.11%. The algorithm had correctly predicted 8 out 10 stocks correctly during the 1-Month period.

Sarepta Therapeutics, Inc. (SRPT) is a biopharmaceutical company focusing on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. Its lead product candidate is Eteplirsen.  The company was founded in 1890 and is headquartered in Cambridge, United Kingdom.

How to interpret this diagram

Please, note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.